[Measurement of glycosylated hemoglobin as a useful method for controlling type II diabetes mellitus in patients suspected of incomplete compensation].
The conduction of levels of glycosylated hemoglobin in patients with type II diabetes mellitus was studied A group of 111 ambulant patients was analyzed and special attention paid to those patients who were given the highest permissible oral dose. The dependence between the achieved glycosylation tests results and types of therapy, the clinical course of diabetes mellitus, as well as the conduction of results of standard compensation tests was analyzed. A lower correlation degree between the level of HbA1 and the results of standard compensation tests was indicated. At the same time a high correlation degree between HbA1 and clinically proven diabetes complication progress was observed. All achieved results suggest the usefulness of HbA1 determination in patients with type II diabetes mellitus suspected of incomplete compensation for instance treated highest permissible oral dose.